Protagonist Therapeutics (PTGX) Accumulated Depreciation (2015 - 2026)
Protagonist Therapeutics' Accumulated Depreciation came in at $9.12 million for Q2 2026, up 20.3% from $7.58 million a year earlier and up 4.6% from the prior quarter.
Protagonist Therapeutics (PTGX) Accumulated Depreciation (2015 - 2026) Analysis & Trends
At the end of FY2025, Protagonist Therapeutics' Accumulated Depreciation was $8.32 million, up 18.2% from FY2024.
- Accumulated Depreciation has increased in each of the last ten years, with a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- Going back by year, Accumulated Depreciation was $7.04 million in FY2024 (+12.8%), $6.23 million in FY2023 (+18.7%), $5.25 million in FY2022 (+23.4%) and $4.26 million in FY2021 (+22.6%).
- The Q2 2026 figure represents the highest quarterly Accumulated Depreciation in data going back to Q4 2015.
- Year-over-year, Accumulated Depreciation has increased for 15 consecutive quarters, with growth averaging 16.0% over the last eight quarters.
- The year-over-year growth in Accumulated Depreciation has ranged between 12.4% (Q1 2025) and 23.4% (Q4 2022) over the last five years.
- Business Quant data shows PTGX's Accumulated Depreciation at $8.72 million (Q1 2026), $8.32 million (Q4 2025) and $7.94 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Protagonist Therapeutics | 9.11 Bn | 9.11 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.12 Mn |
| Mar 31, 2026 | 8.72 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Sep 30, 2025 | 7.94 Mn |
| Jun 30, 2025 | 7.58 Mn |
| Mar 31, 2025 | 7.27 Mn |
| Dec 31, 2024 | 7.04 Mn |
| Sep 30, 2024 | 6.93 Mn |
| Jun 30, 2024 | 6.70 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 6.23 Mn |
| Sep 30, 2023 | 5.95 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 5.49 Mn |
| Dec 31, 2022 | 5.25 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 4.74 Mn |
| Mar 31, 2022 | 4.53 Mn |
| Dec 31, 2021 | 4.26 Mn |
| Dec 31, 2020 | 3.47 Mn |
Protagonist Therapeutics Accumulated Depreciation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=PTGX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-depreciation", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();